World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Postcholecystectomy Syndrome (PCS) include symptoms persist or emerge post-gallbladder removal surgery.
Symptoms may be caused by gallbladder issues or new symptoms commonly associated with gallbladder problems. The symptoms of gastrointestinal and biliary issues can arise years post-surgery.
PCS recognized in early 20th century with cholecystectomy common for gallstones and cholecystitis management.
PCS is a preliminary diagnosis based on improper bile flow. It should be renamed to reflect the underlying disease detected.
Problems can arise from excessive bile flow into upper GI tract causes esophagitis and gastritis.
Diarrhea and abdominal pain are common lower GI symptoms related to PCS.
Epidemiology
PCS affects 10-40% of patient’s post-surgery. It is more common in middle-aged women and those with gastrointestinal disorders.
Incidence of PCS ranges from 5-30%, with 10-15% considered the most reasonable estimate.
Patients with preoperative psychiatric disorder have a higher chance of organic cause of PCS compared to patients without.
Patients with shorter preoperative symptom duration have lower risk develops PCS post-surgery.
Anatomy
Pathophysiology
Bile from gallbladder may cause PCS in patients with mild symptoms. Removal of the gallbladder changes bile flow and circulation.
Initial PCS research emphasized visually detectable anatomic abnormalities during exploratory surgery.
Advancements in technology and imaging have enhanced comprehension of biliary tract disorders in patients.
PCS complexity includes bile dynamics, motility disorders, and gastrointestinal disturbances changes.
Gallbladder removal can resolve gallstone symptoms but may cause new issues thorough diagnostic and treatment plan.
Etiology
The causes of PCS are:
Biliary Causes
Non-Biliary Causes
Surgical Factors
Psychosocial Factors
Genetics
Prognostic Factors
Results and outlook depend on patients, conditions, and performed operations in healthcare.
PCS prognosis depends on cause and treatment. Proper identification and treatment lead to relief.
SOD patients prone to RUQ pain may need sphincterotomy or stenting for symptom relief uncertainty.
Successful treatment with antibiotics improves prognosis but recurrence is common if not addressed.
Clinical History
Collect details including presenting symptoms and surgical history to understand clinical history of patient.
Physical Examination
Skin Examination
Abdominal Examination
Gastrointestinal examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Acute symptoms are:
Sudden right upper quadrant pain, nausea, vomiting, fever, jaundice, guarding, fever, nausea, vomiting, and fever.
Chronic symptoms are:
Chronic diarrhea, bloating, flatulence, intermittent abdominal discomfort, bloating, and changes in bowel habits.
Differential Diagnoses
Sphincter of Oddi Dysfunction
Biliary Stricture
Irritable Bowel Syndrome
Bile Acid Malabsorption
Hepatitis
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Postcholecystectomy syndrome is temporary. Diagnosis is usually organic or functional after workup.
Follow the established diagnosis for appropriate medical or surgical treatment for best results.
Patients with irritable bowel syndrome show improvement with bulking agents, antispasmodics, or sedatives.
Irritable sphincter may require high-dose calcium-channel blockers or nitrates.
H2 blockers and PPIs may help GERD or gastritis symptoms in some patients.
Avoid exploratory surgery for patients abusing alcohol or narcotics until substance abuse stops.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-postcholecystectomy-syndrome
A balanced diet rich in fruits, vegetables, and whole grains should be consumed to improve health.
Patient should make changes in homes environment to increase safety and accessibility.
Reduce night-time reflux to prevent bile from flowing back into the stomach.
Proper awareness about PCS should be provided and its related causes with management strategies.
Appointments with a physician and preventing recurrence of disorder is an ongoing life-long effort.
Use of Bulking Agents
Psyllium:
It increases the content of feces to promote bacterial growth.
Use of Antispasmodic Agents
Atropine:
It blocks acetylcholine activity at parasympathetic sites in smooth muscles and secretory glands.
Use of Bile Acid Sequestrants
Cholestyramine:
It binds with bile acids to reduce damage to the intestinal mucosa.
Colestipol:
It increases fecal loss of bile acid–bound low-density lipoprotein cholesterol.
Use of Histamine H2 Antagonists
Nizatidine:
It inhibits histamine at the H2 receptor of the gastric parietal cells,
Cimetidine:
It blocks H2 receptors to inhibit gastric secretions.
Use of Proton pump inhibitors
Pantoprazole:
It decreases gastric acid secretion to inhibit the parietal cell H+/K+ -ATP pump.
Esomeprazole:
It inhibits gastric acid secretion at the secretory surface of the gastric parietal cells.
Omeprazole:
It is used for short-term and long-term treatment of gastroesophageal reflux disease.
use-of-intervention-with-a-procedure-in-treating-postcholecystectomy-syndrome
Surgery for PCS is recommended for known causes that respond well to operative intervention.
Endoscopic retrograde cholangiopancreatography is used for diagnosis and treatment.
use-of-phases-in-managing-postcholecystectomy-syndrome
In the initial treatment phase, evaluation of surgical history, physical examination and diagnostic testing to confirm diagnosis.
Pharmacologic therapy is effective in the treatment phase as it includes use of bulking agents, antispasmodic agents, bile acid sequestrants, and proton pump inhibitors.
In supportive care and management phase, patients should receive required attention such as lifestyle modification and surgical intervention.
The regular follow-up visits with the physician are scheduled to check the improvement of patients along with treatment response.
Medication
Future Trends
Postcholecystectomy Syndrome (PCS) include symptoms persist or emerge post-gallbladder removal surgery.
Symptoms may be caused by gallbladder issues or new symptoms commonly associated with gallbladder problems. The symptoms of gastrointestinal and biliary issues can arise years post-surgery.
PCS recognized in early 20th century with cholecystectomy common for gallstones and cholecystitis management.
PCS is a preliminary diagnosis based on improper bile flow. It should be renamed to reflect the underlying disease detected.
Problems can arise from excessive bile flow into upper GI tract causes esophagitis and gastritis.
Diarrhea and abdominal pain are common lower GI symptoms related to PCS.
PCS affects 10-40% of patient’s post-surgery. It is more common in middle-aged women and those with gastrointestinal disorders.
Incidence of PCS ranges from 5-30%, with 10-15% considered the most reasonable estimate.
Patients with preoperative psychiatric disorder have a higher chance of organic cause of PCS compared to patients without.
Patients with shorter preoperative symptom duration have lower risk develops PCS post-surgery.
Bile from gallbladder may cause PCS in patients with mild symptoms. Removal of the gallbladder changes bile flow and circulation.
Initial PCS research emphasized visually detectable anatomic abnormalities during exploratory surgery.
Advancements in technology and imaging have enhanced comprehension of biliary tract disorders in patients.
PCS complexity includes bile dynamics, motility disorders, and gastrointestinal disturbances changes.
Gallbladder removal can resolve gallstone symptoms but may cause new issues thorough diagnostic and treatment plan.
The causes of PCS are:
Biliary Causes
Non-Biliary Causes
Surgical Factors
Psychosocial Factors
Results and outlook depend on patients, conditions, and performed operations in healthcare.
PCS prognosis depends on cause and treatment. Proper identification and treatment lead to relief.
SOD patients prone to RUQ pain may need sphincterotomy or stenting for symptom relief uncertainty.
Successful treatment with antibiotics improves prognosis but recurrence is common if not addressed.
Collect details including presenting symptoms and surgical history to understand clinical history of patient.
Skin Examination
Abdominal Examination
Gastrointestinal examination
Acute symptoms are:
Sudden right upper quadrant pain, nausea, vomiting, fever, jaundice, guarding, fever, nausea, vomiting, and fever.
Chronic symptoms are:
Chronic diarrhea, bloating, flatulence, intermittent abdominal discomfort, bloating, and changes in bowel habits.
Sphincter of Oddi Dysfunction
Biliary Stricture
Irritable Bowel Syndrome
Bile Acid Malabsorption
Hepatitis
Postcholecystectomy syndrome is temporary. Diagnosis is usually organic or functional after workup.
Follow the established diagnosis for appropriate medical or surgical treatment for best results.
Patients with irritable bowel syndrome show improvement with bulking agents, antispasmodics, or sedatives.
Irritable sphincter may require high-dose calcium-channel blockers or nitrates.
H2 blockers and PPIs may help GERD or gastritis symptoms in some patients.
Avoid exploratory surgery for patients abusing alcohol or narcotics until substance abuse stops.
Surgery, General
A balanced diet rich in fruits, vegetables, and whole grains should be consumed to improve health.
Patient should make changes in homes environment to increase safety and accessibility.
Reduce night-time reflux to prevent bile from flowing back into the stomach.
Proper awareness about PCS should be provided and its related causes with management strategies.
Appointments with a physician and preventing recurrence of disorder is an ongoing life-long effort.
Surgery, General
Psyllium:
It increases the content of feces to promote bacterial growth.
Surgery, General
Atropine:
It blocks acetylcholine activity at parasympathetic sites in smooth muscles and secretory glands.
Surgery, General
Cholestyramine:
It binds with bile acids to reduce damage to the intestinal mucosa.
Colestipol:
It increases fecal loss of bile acid–bound low-density lipoprotein cholesterol.
Surgery, General
Nizatidine:
It inhibits histamine at the H2 receptor of the gastric parietal cells,
Cimetidine:
It blocks H2 receptors to inhibit gastric secretions.
Surgery, General
Pantoprazole:
It decreases gastric acid secretion to inhibit the parietal cell H+/K+ -ATP pump.
Esomeprazole:
It inhibits gastric acid secretion at the secretory surface of the gastric parietal cells.
Omeprazole:
It is used for short-term and long-term treatment of gastroesophageal reflux disease.
Surgery, General
Surgery for PCS is recommended for known causes that respond well to operative intervention.
Endoscopic retrograde cholangiopancreatography is used for diagnosis and treatment.
Surgery, General
In the initial treatment phase, evaluation of surgical history, physical examination and diagnostic testing to confirm diagnosis.
Pharmacologic therapy is effective in the treatment phase as it includes use of bulking agents, antispasmodic agents, bile acid sequestrants, and proton pump inhibitors.
In supportive care and management phase, patients should receive required attention such as lifestyle modification and surgical intervention.
The regular follow-up visits with the physician are scheduled to check the improvement of patients along with treatment response.
Postcholecystectomy Syndrome (PCS) include symptoms persist or emerge post-gallbladder removal surgery.
Symptoms may be caused by gallbladder issues or new symptoms commonly associated with gallbladder problems. The symptoms of gastrointestinal and biliary issues can arise years post-surgery.
PCS recognized in early 20th century with cholecystectomy common for gallstones and cholecystitis management.
PCS is a preliminary diagnosis based on improper bile flow. It should be renamed to reflect the underlying disease detected.
Problems can arise from excessive bile flow into upper GI tract causes esophagitis and gastritis.
Diarrhea and abdominal pain are common lower GI symptoms related to PCS.
PCS affects 10-40% of patient’s post-surgery. It is more common in middle-aged women and those with gastrointestinal disorders.
Incidence of PCS ranges from 5-30%, with 10-15% considered the most reasonable estimate.
Patients with preoperative psychiatric disorder have a higher chance of organic cause of PCS compared to patients without.
Patients with shorter preoperative symptom duration have lower risk develops PCS post-surgery.
Bile from gallbladder may cause PCS in patients with mild symptoms. Removal of the gallbladder changes bile flow and circulation.
Initial PCS research emphasized visually detectable anatomic abnormalities during exploratory surgery.
Advancements in technology and imaging have enhanced comprehension of biliary tract disorders in patients.
PCS complexity includes bile dynamics, motility disorders, and gastrointestinal disturbances changes.
Gallbladder removal can resolve gallstone symptoms but may cause new issues thorough diagnostic and treatment plan.
The causes of PCS are:
Biliary Causes
Non-Biliary Causes
Surgical Factors
Psychosocial Factors
Results and outlook depend on patients, conditions, and performed operations in healthcare.
PCS prognosis depends on cause and treatment. Proper identification and treatment lead to relief.
SOD patients prone to RUQ pain may need sphincterotomy or stenting for symptom relief uncertainty.
Successful treatment with antibiotics improves prognosis but recurrence is common if not addressed.
Collect details including presenting symptoms and surgical history to understand clinical history of patient.
Skin Examination
Abdominal Examination
Gastrointestinal examination
Acute symptoms are:
Sudden right upper quadrant pain, nausea, vomiting, fever, jaundice, guarding, fever, nausea, vomiting, and fever.
Chronic symptoms are:
Chronic diarrhea, bloating, flatulence, intermittent abdominal discomfort, bloating, and changes in bowel habits.
Sphincter of Oddi Dysfunction
Biliary Stricture
Irritable Bowel Syndrome
Bile Acid Malabsorption
Hepatitis
Postcholecystectomy syndrome is temporary. Diagnosis is usually organic or functional after workup.
Follow the established diagnosis for appropriate medical or surgical treatment for best results.
Patients with irritable bowel syndrome show improvement with bulking agents, antispasmodics, or sedatives.
Irritable sphincter may require high-dose calcium-channel blockers or nitrates.
H2 blockers and PPIs may help GERD or gastritis symptoms in some patients.
Avoid exploratory surgery for patients abusing alcohol or narcotics until substance abuse stops.
Surgery, General
A balanced diet rich in fruits, vegetables, and whole grains should be consumed to improve health.
Patient should make changes in homes environment to increase safety and accessibility.
Reduce night-time reflux to prevent bile from flowing back into the stomach.
Proper awareness about PCS should be provided and its related causes with management strategies.
Appointments with a physician and preventing recurrence of disorder is an ongoing life-long effort.
Surgery, General
Psyllium:
It increases the content of feces to promote bacterial growth.
Surgery, General
Atropine:
It blocks acetylcholine activity at parasympathetic sites in smooth muscles and secretory glands.
Surgery, General
Cholestyramine:
It binds with bile acids to reduce damage to the intestinal mucosa.
Colestipol:
It increases fecal loss of bile acid–bound low-density lipoprotein cholesterol.
Surgery, General
Nizatidine:
It inhibits histamine at the H2 receptor of the gastric parietal cells,
Cimetidine:
It blocks H2 receptors to inhibit gastric secretions.
Surgery, General
Pantoprazole:
It decreases gastric acid secretion to inhibit the parietal cell H+/K+ -ATP pump.
Esomeprazole:
It inhibits gastric acid secretion at the secretory surface of the gastric parietal cells.
Omeprazole:
It is used for short-term and long-term treatment of gastroesophageal reflux disease.
Surgery, General
Surgery for PCS is recommended for known causes that respond well to operative intervention.
Endoscopic retrograde cholangiopancreatography is used for diagnosis and treatment.
Surgery, General
In the initial treatment phase, evaluation of surgical history, physical examination and diagnostic testing to confirm diagnosis.
Pharmacologic therapy is effective in the treatment phase as it includes use of bulking agents, antispasmodic agents, bile acid sequestrants, and proton pump inhibitors.
In supportive care and management phase, patients should receive required attention such as lifestyle modification and surgical intervention.
The regular follow-up visits with the physician are scheduled to check the improvement of patients along with treatment response.

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
